Effectdossier · gearchiveerd kwartaal
IHE
iShares U.S. Pharmaceuticals ETF · Financial Services · Asset Management
48Gevolgde houders
+1Δ houders
4.98MGehouden aandelen
$422.06MGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +2.1% ·
aandelenstroom +3.8% ·
netto nieuwe posities +2.1%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 10.79K | $1.07M | n/a | −1 |
| Q2 2026 | 51 | +4 | 6.30M | $624.73M | +6 | −3 |
| Q1 2026 | 49 | +1 | 5.21M | $450.70M | +3 | −2 |
| Q4 2025 | 48 | +1 | 4.98M | $422.06M | +1 | n/a |
| Q3 2025 | 7 | +1 | 3.46M | $251.38M | +1 | n/a |
| Q2 2025 | 3 | 0 | 3.03M | $198.38M | n/a | n/a |
| Q1 2025 | 2 | -2 | 3.17M | $223.35M | n/a | −2 |
| Q4 2024 | 4 | +1 | 3.32M | $218.11M | +2 | −1 |
| Q3 2024 | 3 | -2 | 3.37M | $237.66M | n/a | −2 |
| Q2 2024 | 5 | n/a | 3.48M | $230.98M | n/a | n/a |
Wie het bezit · Q4 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management ✦ | 2.83M | -2.1% | $239.70M | 0.1% | ▼ Trim | 7 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 472.58K | +151.7% | $40.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | Bank Of America Corp /De/ | 444.04K | n/a | $37.67M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | JPMorgan Chase ✦ | 212.81K | -5.3% | $18.05M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 5 | Royal Bank Of Canada | 156.97K | n/a | $13.31M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 6 | LPL Financial LLC | 137.75K | n/a | $11.69M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Bnp Paribas Financial Markets | 103.02K | n/a | $8.74M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Goldman Sachs Group ✦ | 82.88K | -43.1% | $7.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Brown Advisory Inc | 75.43K | n/a | $6.40M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Raymond James Financial Inc | 56.06K | n/a | $4.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 11 | Wells Fargo & Company/Mn | 50.91K | n/a | $4.32M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Osaic Holdings, Inc. | 42.67K | n/a | $3.62M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | UBS Group AG | 38.81K | n/a | $3.29M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Commonwealth Equity Services, Llc | 26.52K | n/a | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Ameriprise Financial Inc | 25.55K | n/a | $2.17M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Mariner, LLC | 25.37K | n/a | $2.15M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Bank Of Montreal /Can/ | 22.47K | n/a | $1.91M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 18 | Citadel Advisors ✦ | 21.39K | +213.0% | $1.81M | 0.0% | ▲ Add | 7 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 14.79K | +14.7% | $1.25M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 20 | Jones Financial Companies Lllp | 14.69K | n/a | $1.25M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 14.34K | Nieuw | $1.22M | 0.0% | New | 1 | SEC ↗ ×2 |
| 22 | Cetera Investment Advisers | 14.12K | n/a | $1.20M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Corient Private Wealth LP | 13.01K | n/a | $1.10M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 24 | HighTower Advisors, LLC | 9.08K | n/a | $770,245 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Truist Financial Corp | 8.61K | n/a | $730,678 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Stifel Financial Corp | 8.47K | n/a | $718,247 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 27 | Mercer Global Advisors Inc /Adv | 8.21K | n/a | $696,230 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Envestnet Asset Management Inc | 6.61K | n/a | $560,305 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Creative Planning | 6.59K | n/a | $558,650 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Rockefeller Capital Management L.P. | 6.42K | n/a | $544,204 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Captrust Financial Advisors | 4.91K | n/a | $416,728 | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Wealth Enhancement Advisory… | 4.70K | n/a | $397,329 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Mml Investors Services, Llc | 3.55K | n/a | $301,118 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Focus Partners Wealth | 3.43K | n/a | $291,005 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Susquehanna International Group, Llp | 2.71K | n/a | $229,889 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Northwestern Mutual Wealth… | 2.55K | n/a | $216,571 | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Pnc Financial Services Group, Inc. | 2.42K | n/a | $204,949 | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Fifth Third Bancorp | 1.17K | n/a | $98,997 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | TD Waterhouse Canada Inc. | 870 | n/a | $73,741 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Cwm, Llc | 776 | n/a | $66,000 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | National Bank Of Canada /Fi/ | 521 | n/a | $44,160 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Assetmark, Inc | 465 | n/a | $39,446 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Citigroup Inc | 433 | n/a | $36,731 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Russell Investments Group, Ltd. | 389 | n/a | $32,999 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | UBS AM, a distinct business unit of… | 288 | n/a | $24,431 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Franklin Resources Inc | 198 | n/a | $16,796 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Us Bancorp \De\ | 162 | n/a | $13,742 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | BlackRock ✦ (passief) | 33 | 0.0% | $2,799 | 0.0% | Held | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $1.22M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 193 houders, 7.24M aandelen, $621.44M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q4 2025 ·
Methodologie ·
Verkrijg dit via de API